The 2017 Bethesda System For Reporting Thyroid Cytopathology.
Edmund S Cibas, Syed Zulfiqar Ali
Published 2017 · Medicine
Download PDFAnalyze on Scholarcy
The Bethesda System for Reporting Thyroid Cytopathology (TBSRTC) established a standardized, category-based reporting system for thyroid fine-needle aspiration (FNA) specimens. The 2017 revision reaffirms that every thyroid FNA report should begin with one of six diagnostic categories, the names of which remain unchanged since they were first introduced: (i) nondiagnostic or unsatisfactory; (ii) benign; (iii) atypia of undetermined significance (AUS) or follicular lesion of undetermined significance (FLUS); (iv) follicular neoplasm or suspicious for a follicular neoplasm; (v) suspicious for malignancy; and (vi) malignant. There is a choice of two different names for some of the categories. A laboratory should choose the one it prefers and use it exclusively for that category. Synonymous terms (e.g., AUS and FLUS) should not be used to denote two distinct interpretations. Each category has an implied cancer risk that ranges from 0% to 3% for the "benign" category to virtually 100% for the "malignant" category, and, in the 2017 revision, the malignancy risks have been updated based on new (post 2010) data. As a function of their risk associations, each category is linked to updated, evidence-based clinical management recommendations. The recent reclassification of some thyroid neoplasms as noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP) has implications for the risk of malignancy, and this is accounted for with regard to diagnostic criteria and optional notes. Such notes can be useful in helping guide surgical management.
This paper references
Nomenclature Revision for Encapsulated Follicular Variant of Papillary Thyroid Carcinoma: A Paradigm Shift to Reduce Overtreatment of Indolent Tumors.
Yuri E Nikiforov (2016)
L. von Lesser (2006)
The Impact of Noninvasive Follicular Variant of Papillary Thyroid Carcinoma on Rates of Malignancy for Fine-Needle Aspiration Diagnostic Categories.
Kyle C. Strickland (2015)
Papillary thyroid carcinoma with atypical histiocytoid cells on fine-needle aspiration.
Manju Harshan (2009)
Impact of reclassifying noninvasive follicular variant of papillary thyroid carcinoma on the risk of malignancy in The Bethesda System for Reporting Thyroid Cytopathology.
William C Faquin (2016)
The Bethesda System for Reporting Cervical Cytology
Ritu Nayar (2004)
ES Cibas (2009)
Fine-needle aspiration of follicular lesions of the thyroid
MS Deveci (2006)
THYROID BETHESDA SYSTEM
YE Nikiforov (2017)
Factors that predict malignant thyroid lesions when fine-needle aspiration is "suspicious for follicular neoplasm".
Richard T. Schlinkert (1997)
Fine-needle aspiration of follicular lesions of the thyroid. Diagnosis and follow-Up
Mehmet Salih Deveci (2006)
Coming to terms with NIFTP: A provisional approach for cytologists.
Jeffrey F Krane (2016)
Timing of Repeat Thyroid Fine-Needle Aspiration in the Management of Thyroid Nodules
Remmi S Singh (2011)
Repeat Fine-Needle Aspiration Biopsy within a Short Interval Does Not Increase the Atypical Cytologic Results for Thyroid Nodules with Previously Nondiagnostic Results
Ha Young Lee (2014)
carcinoma on rates of malignancy for fi ne - needle aspiration diagnostic categories
WC Faquin (2015)
Diagnosis of "follicular neoplasm": a gray zone in thyroid fine-needle aspiration cytology.
Zubair W Baloch (2002)
“ Histiocytoid ” cells in fi ne - needle aspirations of papillary carcinoma of the thyroid : frequency and signi fi cance of an underrecognized cytologic pattern
M Harshan (2002)
Histologic follow-up of nondiagnostic thyroid fine needle aspirations: implications for adequacy criteria.
Andrew A Renshaw (2012)
Thyroid cytology and the risk of malignancy in thyroid nodules: importance of nuclear atypia in indeterminate specimens.
Avi Kelman (2001)
The Bethesda system for reporting thyroid cytopathology : definitions, criteria, and explanatory notes
Syed Zulfiqar Ali (2010)
"Histiocytoid" cells in fine-needle aspirations of papillary carcinoma of the thyroid: frequency and significance of an under-recognized cytologic pattern.
Andrew A Renshaw (2002)
Adequacy criteria for thyroid FNA evaluated by ThinPrep slides only
Marina Vivero (2017)
The impact of non - invasive follicular variant of papillary
KC Strickland (2015)
Evidence for overestimation of the prevalence of malignancy in indeterminate thyroid nodules classified as Bethesda category III.
Mazen E. Iskandar (2015)
Fine-needle aspiration of thyroid nodules: a study of 4703 patients with histologic and clinical correlations.
Jack Yang (2007)
Cyto - pathology
ES Cibas (2009)
The Bethesda System For Reporting Thyroid Cytopathology.
Edmund S Cibas (2009)
American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer : The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer.
B Haugen (2016)
The Bethesda System for Reporting Thyroid Cytopathology
Dharmendra Kumar (2018)
The Bethesda System for Reporting Thyroid Cytopathology: proposed modifications and updates for the second edition from an international panel.
Marc P Pusztaszeri (2016)
Cystic papillary thyroid carcinoma in fine needle aspiration may represent a subset of the encapsulated variant in WHO classification.
Grace C H Yang (2010)
This paper is referenced by
Strain Elastography as a Valuable Diagnosis Tool in Intermediate Cytology (Bethesda III) Thyroid Nodules
Dana Stoian (2019)
The surgical dilemma of primary surgery for follicular thyroid neoplasms.
J I Staubitz (2019)
The genetic heterogeneity of indeterminate thyroid nodules assessed preoperatively with next generation sequencing reflects the diversity of the final histopathological diagnoses.
Martyna Borowczyk (2019)
McGill Thyroid Nodule Score in Differentiating Thyroid Nodules in Total Thyroidectomy Cases of Indeterminate Nodules
Hadi Afandi Al-Hakami (2020)
Papillary Thyroid Carcinoma With Cystic Changes in a Patient With Prior History of Toxic Nodule
Gliceida Maria Galarza Fortuna (2020)
Utility of subcategorization of atypia of undetermined significance/follicular lesion of undetermined significance category in ultrasound-guided thyroid fine-needle aspiration in a large referral cancer center.
Qiong Gan (2019)
Estudo do papel de TGF-ß1 no carcinoma diferenciado da tireoide
Karina Colombera Peres (2018)
Noninvasive follicular thyroid neoplasm with papillary-like nuclear features and the risk of malignancy in The Bethesda System for the Reporting of Thyroid Cytopathology.
Danielle Elliott Range (2020)
Fine Needle Aspiration of Benign Thyroid Nodules
Rana S. Hoda (2020)
Histologic Outcome of Indeterminate Thyroid Nodules Classified at Low or High Risk
Pierpaolo Trimboli (2018)
European Thyroid Association Survey on Use of Minimally Invasive Techniques for Thyroid Nodules
Laszlo Hegedüs (2020)
Cytomorphological Analysis of Thyroid Nodules Diagnosed as Follicular Variant of Papillary Thyroid Carcinoma: a Fine Needle Aspiration Study of Diagnostic Clues in 42 Cases and the Impact of Using Bethesda System in Reporting—an Institutional Experience
Levent Trabzonlu (2018)
Impact of the modification of the diagnostic criteria in the 2017 Bethesda System for Reporting Thyroid Cytopathology: a report of a single institution in Japan.
Miyoko Higuchi (2018)
Molecular markers for the classification of cytologically indeterminate thyroid nodules
Marina Muzza (2019)
Serous cavity fluids: Momentum, molecules, markers… and more!
Momin T Siddiqui (2020)
Association between Tsukuba elasticity scores 4 and 5 on elastography and Bethesda undetermined cytology on US-guided FNA with 27-G needle, verified by histopathology: a cut-off point of 20 mm of diameter designated for thyroid nodules.
Demet Sengul (2019)
The Afirma Xpression Atlas for thyroid nodules and thyroid cancer metastases: Insights to inform clinical decision‐making from a fine‐needle aspiration sample
Jeffrey F Krane (2020)
The role of breast FNA during and post‐ COVID‐19 pandemic: a fast and safe alternative to needle core biopsy
Daniel Pinto (2020)
Cytologic Diagnosis of Noninvasive Follicular Thyroid Neoplasm with Papillary-like Nuclear Features and Its Impact on the Risk of Malignancy in the Bethesda System for Reporting Thyroid Cytopathology: An Institutional Experience
Milim Kim (2018)
Comparison of Number of Passes and Cytopathological Specimen Adequacy for Thyroid Fine-Needle Aspiration Biopsy in the Absence of an On-Site Pathologist
Taha Y. Kuzan (2019)
Comparison of the Bethesda system classification and postoperative cytology of thyroid nodules: A single center experience
Yasar Ozdenkaya (2019)
Whole-genome sequencing of synchronous thyroid carcinomas identifies aberrant DNA repair in thyroid cancer dedifferentiation.
Johan O. Paulsson (2019)
Ultrasound-Guided Fine Needle Aspiration Biopsy
Yuriy K. Aleksandrov (2019)
A retrospective study correlating sonographic features of thyroid nodules with fine-needle aspiration cytology in a South African setting
Mark Andrew Nicolaou (2019)
tyreopatie by měl léčit a dispenzarizovat všeobecný praktický lékař pro dospělé ? doc
Jan Jiskra (2019)
NCCN Guidelines Insights: Thyroid Carcinoma, Version 2.2018.
Robert I. Haddad (2018)
Clinical analysis of false-negative fine needle aspiration cytology of head and neck cancers
Seiji Hosokawa (2019)
Ultrasonography in Diagnosis and Management of Thyroid Cancer: Current International Recommendations
Dong Gyu Na (2018)
An Institutional Analysis of Malignancy Rate in Bethesda III and IV Nodules of the Thyroid
Abbas Al-Kurd (2019)
Long-Term Outcomes of Thyroid Nodule AFIRMA GEC Testing and Literature Review: An Institutional Experience
Amy Vora (2020)
The Diagnostic Performance of Afirma Gene Expression Classifier for the Indeterminate Thyroid Nodules: A Meta-Analysis
Ying Liu (2019)
Tumour growth rate of follicular thyroid carcinoma is not different from that of follicular adenoma
Mijin Kim (2018)See more